These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24373162)

  • 41. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
    Bunin N; Aplenc R; Iannone R; Leahey A; Grupp S; Monos D; Pierson G
    Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intestinal transplantation in children: the first successful Italian series.
    Colledan M; Stroppa P; Bravi M; Casotti V; Lucianetti A; Pinelli D; Zambelli M; Guizzetti M; Corno V; Aluffi A; Sonzogni V; Sonzogni A; D'Antiga L; Codazzi D
    Transplant Proc; 2010 May; 42(4):1251-2. PubMed ID: 20534273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
    Schmid I; Stachel D; Pagel P; Albert MH
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
    Mengarelli A; Iori AP; Romano A; Cerretti R; Cerilli L; De Propris MS; Fenu S; Moleti ML; De Felice L; Girelli G; Arcese W
    Haematologica; 2003 Mar; 88(3):315-23. PubMed ID: 12651271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency.
    Gilroy RK; Coccia PF; Talmadge JE; Hatcher LI; Pirruccello SJ; Shaw BW; Rubocki RJ; Sudan DL; Langnas AN; Horslen SP
    Blood; 2004 Feb; 103(3):1171-4. PubMed ID: 14525785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
    Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
    Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
    Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M
    Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pretransplant conditioning with Campath-1H (alemtuzumab) in pediatric matched unrelated hematopoietic stem cell transplants: an institutional experience.
    Nageswara Rao AA; Kumar R; Altaf S; Gourde JA; Rodriguez V; Khan SP
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):96-100. PubMed ID: 22146532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of end-stage central venous access in children referred for possible small bowel transplantation.
    Rodrigues AF; van Mourik ID; Sharif K; Barron DJ; de Giovanni JV; Bennett J; Bromley P; Protheroe S; John P; de Ville de Goyet J; Beath SV
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):427-33. PubMed ID: 16641582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias.
    Chen R; Giliani S; Lanzi G; Mias GI; Lonardi S; Dobbs K; Manis J; Im H; Gallagher JE; Phanstiel DH; Euskirchen G; Lacroute P; Bettinger K; Moratto D; Weinacht K; Montin D; Gallo E; Mangili G; Porta F; Notarangelo LD; Pedretti S; Al-Herz W; Alfahdli W; Comeau AM; Traister RS; Pai SY; Carella G; Facchetti F; Nadeau KC; Snyder M; Notarangelo LD
    J Allergy Clin Immunol; 2013 Sep; 132(3):656-664.e17. PubMed ID: 23830146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
    Ringdén O; Uzunel M; Rasmusson I; Remberger M; Sundberg B; Lönnies H; Marschall HU; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
    Transplantation; 2006 May; 81(10):1390-7. PubMed ID: 16732175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors.
    Yan CH; Liu DH; Xu LP; Liu KY; Zhao T; Wang Y; Chen H; Chen YH; Han W; Huang XJ
    Clin Transplant; 2012; 26(6):868-76. PubMed ID: 22432715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twenty-eight years of intestinal transplantation in Paris: experience of the oldest European center.
    Lacaille F; Irtan S; Dupic L; Talbotec C; Lesage F; Colomb V; Salvi N; Moulin F; Sauvat F; Aigrain Y; Revillon Y; Goulet O; Chardot C
    Transpl Int; 2017 Feb; 30(2):178-186. PubMed ID: 27889929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Graft-versus-host disease in paediatric solid organ transplantation: A review of the literature.
    Green T; Hind J
    Pediatr Transplant; 2016 Aug; 20(5):607-18. PubMed ID: 27198497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple areas of intestinal atresia associated with immunodeficiency and posttransfusion graft-versus-host disease.
    Walker MW; Lovell MA; Kelly TE; Golden W; Saulsbury FT
    J Pediatr; 1993 Jul; 123(1):93-5. PubMed ID: 8320633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and feasibility of ruxolitinib in chronic steroid-refractory GVHD in a pediatric intestine transplant.
    Ghobrial S; Gonzalez C; Yazigi N; Kaufman S; Matsumoto C; Fishbein T; Hawksworth J; Kroemer A; Khan K
    Pediatr Transplant; 2021 May; 25(3):e13836. PubMed ID: 32981124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Graft versus host disease in intestinal transplantation.
    Mazariegos GV; Abu-Elmagd K; Jaffe R; Bond G; Sindhi R; Martin L; Macedo C; Peters J; Girnita A; Reyes J
    Am J Transplant; 2004 Sep; 4(9):1459-65. PubMed ID: 15307833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune function and infectious complications in children with jejunoileal atresia.
    Prachuapthunyachart S; Merani S; Cloonan M; Langnas AN; Quiros-Tejeira RE; Vo HD
    J Pediatr Surg; 2021 Mar; 56(3):454-458. PubMed ID: 32624206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.